Connor, Clark & Lunn Investment Management (CC&L)’s Wave Life Sciences WVE Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.53M	Buy	624,735 +555,657	+804%	+$7.24M	0.01%	710
2025 Q4	$1.17M	Buy	+69,078	New	+$702K	﹤0.01%	1084
2025 Q2	–	Sell	-126,046	Closed	-$1.02M	–	1706
2025 Q1	$1.02M	Sell	126,046 -261,825	-68%	-$2.86M	﹤0.01%	943
2024 Q4	$4.8M	Buy	387,871 +62,862	+19%	+$839K	0.02%	492
2024 Q3	$2.67M	Sell	325,009 -14,740	-4%	-$88.1K	0.01%	603
2024 Q2	$1.7M	Sell	339,749 -122,833	-27%	-$701K	0.01%	697
2024 Q1	$2.85M	Buy	+462,582	New	+$2.32M	0.01%	574

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

GSK plc London $599M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s WVE Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) increased its Wave Life Sciences (WVE) stake by 804% in Q1 2026, buying an estimated $7.24M and bringing the position to 624,735 shares worth $4.53M. The position accounts for 0.01% of the portfolio, ranked #710.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in WVE in Q1 2024 and has held it in 7 quarters since. The position peaked at $4.8M in Q4 2024. 231 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

Connor, Clark & Lunn Investment Management (CC&L) held 624,735 shares of Wave Life Sciences worth $4.53M as of Q1 2026.
Connor, Clark & Lunn Investment Management (CC&L) bought 555,657 Wave Life Sciences shares in Q1 2026, an estimated $7.24M.
Wave Life Sciences made up 0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #710 holding.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Wave Life Sciences in Q1 2024 and has held it in 7 quarters since.
Connor, Clark & Lunn Investment Management (CC&L)'s Wave Life Sciences position peaked at $4.8M in Q4 2024.
231 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.